These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 26828141)

  • 1. Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra Therapy.
    Etchebehere EC; Araujo JC; Milton DR; Erwin WD; Wendt RE; Swanston NM; Fox P; Macapinlac HA; Rohren EM
    Clin Nucl Med; 2016 Apr; 41(4):268-73. PubMed ID: 26828141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival.
    Etchebehere EC; Araujo JC; Fox PS; Swanston NM; Macapinlac HA; Rohren EM
    J Nucl Med; 2015 Aug; 56(8):1177-84. PubMed ID: 26069307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final Outcome of 223Ra-therapy and the Role of 18F-fluoride-PET in Response Evaluation in Metastatic Castration-resistant Prostate Cancer-A Single Institution Experience.
    Kairemo K; Milton DR; Etchebehere E; Rohren EM; Macapinlac HA
    Curr Radiopharm; 2018; 11(2):147-152. PubMed ID: 29956640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT.
    Rohren EM; Etchebehere EC; Araujo JC; Hobbs BP; Swanston NM; Everding M; Moody T; Macapinlac HA
    J Nucl Med; 2015 Oct; 56(10):1507-12. PubMed ID: 26135112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Burden and Intraosseous Metabolic Activity as Predictors of Bone Marrow Failure during Radioisotope Therapy in Metastasized Prostate Cancer Patients.
    Fiz F; Sahbai S; Campi C; Weissinger M; Dittmann H; Marini C; Piana M; Sambuceti G; la Fougère C
    Biomed Res Int; 2017; 2017():3905216. PubMed ID: 29435457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is interim
    Etchebehere E; Brito AE; Kairemo K; Rohren E; Araujo J; Macapinlac H
    Radiol Bras; 2019; 52(1):33-40. PubMed ID: 30804613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
    Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
    BJU Int; 2012 Nov; 110(10):1501-6. PubMed ID: 22502982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer.
    Brito AE; Santos A; Sasse AD; Cabello C; Oliveira P; Mosci C; Souza T; Amorim B; Lima M; Ramos CD; Etchebehere E
    Oncotarget; 2017 May; 8(22):36001-36011. PubMed ID: 28415595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting (223)Ra therapy: clinical experience after 532 cycles from a single institution.
    Etchebehere EC; Milton DR; Araujo JC; Swanston NM; Macapinlac HA; Rohren EM
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):8-20. PubMed ID: 26416392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of
    Murray I; Chittenden SJ; Denis-Bacelar AM; Hindorf C; Parker CC; Chua S; Flux GD
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1832-1844. PubMed ID: 28612079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of Radium-223 Dichloride and Early [
    Letellier A; Johnson AC; Kit NH; Savigny JF; Batalla A; Parienti JJ; Aide N
    Mol Imaging Biol; 2018 Jun; 20(3):482-491. PubMed ID: 29027074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated?
    Serretta V; Valerio MR; Costa R; Tripoli V; Murabito A; Princiotta A; Scalici Gesolfo C; Borsellino N; Verderame F; Gebbia V; Licari M; Sanfilippo C;
    Urol Oncol; 2019 Dec; 37(12):964-969. PubMed ID: 31601517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11C-choline PET/CT identifies osteoblastic and osteolytic lesions in patients with metastatic prostate cancer.
    Ceci F; Castellucci P; Graziani T; Schiavina R; Chondrogiannis S; Bonfiglioli R; Costa S; Virgolini IJ; Rubello D; Fanti S; Colletti PM
    Clin Nucl Med; 2015 May; 40(5):e265-70. PubMed ID: 25783519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear Medicine Therapy With 223Radium-dichloride for Osseous Metastases in Prostate Carcinoma.
    Wale DJ; Viglianti BL; Gross MD; Ferretti A; Rubello D; Wong KK
    Am J Clin Oncol; 2019 Jan; 42(1):99-106. PubMed ID: 30204613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 68Ga-PSMA-11 PET Represents the Tumoricidal Effect of 223Ra in a Patient With Castrate-Resistant Metastatic Prostate Cancer.
    Ahmadzadehfar H; Schlenkhoff CD; Rogenhofer S; Yordanova A; Essler M
    Clin Nucl Med; 2016 Sep; 41(9):695-6. PubMed ID: 27405025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study.
    Vija Racaru L; Sinigaglia M; Kanoun S; Ben Bouallègue F; Tal I; Brillouet S; Bauriaud-Mallet M; Zerdoud S; Dierickx L; Vallot D; Caselles O; Gabiache E; Pascal P; Courbon F
    Nucl Med Commun; 2018 Jul; 39(7):672-679. PubMed ID: 29790867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-Fluoride positron emission tomography and positron emission tomography/computed tomography.
    Even-Sapir E; Mishani E; Flusser G; Metser U
    Semin Nucl Med; 2007 Nov; 37(6):462-9. PubMed ID: 17920353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-centre Experience of Use of Radium 223 with Clinical Outcomes Based on Number of Cycles and Bone Marrow Toxicity.
    Dadhania S; Alonzi R; Douglas S; Gogbashian A; Hughes R; Dalili D; Vasdev N; Adshead J; Lane T; Westbury C; Anyamene N; Ostler P; Hoskin P; Sharma A
    Anticancer Res; 2018 Sep; 38(9):5423-5427. PubMed ID: 30194198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.